|
1
|
Siegel RL, Miller KD, Wagle NS and Jemal
A: Cancer statistics, 2023. CA Cancer J Clin. 73:17–48. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Duan X, Wang W, Pan Q and Guo L: Type 2
diabetes mellitus intersects with pancreatic cancer diagnosis and
development. Front Oncol. 11:7300382021. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yamaguchi A, Tazuma S, Tamaru Y, Kusunoki
R, Kuwai T, Kouno H, Toyota N, Sudo T, Kuraoka K and Kohno H:
Long-standing diabetes mellitus increases concomitant pancreatic
cancer risk in patients with intraductal papillary mucinous
neoplasms. BMC Gastroenterol. 22:5292022. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bures J, Kohoutova D, Skrha J, Bunganic B,
Ngo O, Suchanek S, Skrha P and Zavoral M: Diabetes mellitus in
pancreatic cancer: A distinct approach to older subjects with
new-onset diabetes mellitus. Cancers (Basel). 15:36692023.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang X, Xu W, Hu X, Yang X and Zhang M:
The prognostic role of glycemia in patients with pancreatic
carcinoma: A systematic review and meta-analysis. Front Oncol.
12:7809092022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lv X, Qiao W, Leng Y, Wu L and Zhou Y:
Impact of diabetes mellitus on clinical outcomes of pancreatic
cancer after surgical resection: A systematic review and
meta-analysis. PLoS One. 12:e01713702017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li Q, Feng Z, Miao R, Liu X, Liu C and Liu
Z: Prognosis and survival analysis of patients with pancreatic
cancer: Retrospective experience of a single institution. World J
Surg Oncol. 20:112022. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Menini S, Iacobini C, de Latouliere L,
Manni I, Vitale M, Pilozzi E, Pesce C, Cappello P, Novelli F,
Piaggio G and Pugliese G: Diabetes promotes invasive pancreatic
cancer by increasing systemic and tumour carbonyl stress in
KrasG12D/+ mice. J Exp Clin Cancer Res. 39:1522020.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gong Y, Fan Z, Zhang P, Qian Y, Huang Q,
Deng S, Luo G, Cheng H, Jin K, Ni Q, et al: High pre-operative
fasting blood glucose levels predict a poor prognosis in patients
with pancreatic neuroendocrine tumour. Endocrine. 71:494–501. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Raghavan SR, Ballehaninna UK and
Chamberlain RS: The impact of perioperative blood glucose levels on
pancreatic cancer prognosis and surgical outcomes: An
evidence-based review. Pancreas. 42:1210–1217. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Andersen DK, Korc M, Petersen GM, Eibl G,
Li D, Rickels MR, Chari ST and Abbruzzese JL: Diabetes,
pancreatogenic diabetes, and pancreatic cancer. Diabetes.
66:1103–1110. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pancreatic Cancer Committee of Chinese
Anticancer Association, . Comprehensive guidelines for the
diagnosis and treatment of pancreatic cancer (2020 version).
Zhonghua Wai Ke Za Zhi. 59:81–100. 2021.(In Chinese). PubMed/NCBI
|
|
13
|
Gonzalez RS, Raza A, Propst R, Adeyi O,
Bateman J, Sopha SC, Shaw J and Auerbach A: Recent advances in
digestive tract tumors: Updates from the 5th edition of the World
Health Organization ‘blue book’. Arch Pathol Lab Med. 145:607–626.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yuan JX, Jiang Q and Yu SJ: Diabetes
mellitus and prostate cancer risk: A mendelian randomization
analysis. World J Diabetes. 14:1839–1848. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang Y, Cao Y and Zhu C: Meta-analysis of
the relationship between type 2 diabetes mellitus and renal cancer
risk. Endocr Metab Immune Disord Drug Targets. 24:832–839. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Boursi B, Finkelman B, Giantonio BJ,
Haynes K, Rustgi AK, Rhim AD, Mamtani R and Yang YX: A clinical
prediction model to assess risk for pancreatic cancer among
patients with new-onset diabetes. Gastroenterology. 152:840–850.e3.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pannala R, Leibson CL, Rabe KG, Timmons
LJ, Ransom J, de Andrade M, Petersen GM and Chari ST: Temporal
association of changes in fasting blood glucose and body mass index
with diagnosis of pancreatic cancer. Am J Gastroenterol.
104:2318–2325. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Goodenough CJ, Liang MK, Nguyen MT, Nguyen
DH, Holihan JL, Alawadi ZM, Roth JS, Wray CJ, Ko TC and Kao LS:
Preoperative glycosylated hemoglobin and postoperative glucose
together predict major complications after abdominal surgery. J Am
Coll Surg. 221:854–861.e1. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang X, Hou A, Cao J, Liu Y, Lou J, Li H,
Ma Y, Song Y, Mi W and Liu J: Association of diabetes mellitus with
postoperative complications and mortality after non-cardiac
surgery: A meta-analysis and systematic review. Front Endocrinol
(Lausanne). 13:8412562022. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dougherty SM, Schommer J, Salinas JL,
Zilles B, Belding-Schmitt M, Rogers WK, Shibli-Rahhal A and O'Neill
BT: Immediate preoperative hyperglycemia correlates with
complications in non-cardiac surgical cases. J Clin Anesth.
74:1103752021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gu J, Liu J, Hong Y, Feng Y and Huang X:
Nomogram for predicting risk factor of urosepsis in patients with
diabetes after percutaneous nephrolithotomy. BMC Anesthesiol.
22:872022. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu S, Xv L, Wu X, Wang F, Wang J, Tang X,
Dong R, Wang B, Lin X and Bi Y: Potential value of preoperative
fasting blood glucose levels in the identification of postoperative
delirium in non-diabetic older patients undergoing total hip
replacement: The perioperative neurocognitive disorder and
biomarker lifestyle study. Front Psychiatry. 13:9410482022.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Balzano G, Dugnani E, Gandolfi A, Scavini
M, Pasquale V, Aleotti F, Liberati D, Di Terlizzi G, Petrella G,
Reni M, et al: Effect of diabetes on survival after resection of
pancreatic adenocarcinoma. A prospective, observational study. PLoS
One. 11:e01660082016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huxley R, Ansary-Moghaddam A, Berrington
de González A, Barzi F and Woodward M: Type-II diabetes and
pancreatic cancer: A meta-analysis of 36 studies. Br J Cancer.
92:2076–2083. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Perazzoli G, Garcia-Valdeavero OM, Peña M,
Prados J, Melguizo C and Jiménez-Luna C: Evaluating
metabolite-based biomarkers for early diagnosis of pancreatic
cancer: A systematic review. Metabolites. 13:8722023. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Meyerhardt JA, Catalano PJ, Haller DG,
Mayer RJ, Macdonald JS, Benson AB III and Fuchs CS: Impact of
diabetes mellitus on outcomes in patients with colon cancer. J Clin
Oncol. 21:433–440. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Abel ED, Gloyn AL, Evans-Molina C, Joseph
JJ, Misra S, Pajvani UB, Simcox J, Susztak K and Drucker DJ:
Diabetes mellitus-progress and opportunities in the evolving
epidemic. Cell. 187:3789–3820. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kleeff J, Korc M, Apte M, La Vecchia C,
Johnson CD, Biankin AV, Neale RE, Tempero M, Tuveson DA, Hruban RH
and Neoptolemos JP: Pancreatic cancer. Nat Rev Dis Primers.
2:160222016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Duffy MJ, Sturgeon C, Lamerz R, Haglund C,
Holubec VL, Klapdor R, Nicolini A, Topolcan O and Heinemann V:
Tumor markers in pancreatic cancer: A European group on tumor
markers (EGTM) status report. Ann Oncol. 21:441–447. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ballehaninna UK and Chamberlain RS: Serum
CA 19-9 as a biomarker for pancreatic cancer-A comprehensive
review. Indian J Surg Oncol. 2:88–100. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bhandare MS, Gupta V, Chaudhari V, Nandy
K, Ostwal V, Ramaswamy A, Nashikkar C, Engineer R, Krishnatry R and
Shrikhande SV: Differential impact of incrementally elevated CA
19-9 levels on prognosis of resected pancreatic ductal
adenocarcinoma. HPB (Oxford). 26:1237–1247. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Guan S, Chen Y, Han Q, Deng G, Wang Y, Shi
Y and Dai G: Preoperative CA19-9 levels predict disease-free
survival and overall survival in pancreatic adenocarcinoma patients
after resection. Transl Cancer Res. 8:811–820. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cummings J, Ward TH, Greystoke A, Ranson M
and Dive C: Biomarker method validation in anticancer drug
development. Br J Pharmacol. 153:646–656. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Currie CJ, Poole CD and Gale EAM: The
influence of glucose-lowering therapies on cancer risk in type 2
diabetes. Diabetologia. 52:1766–1777. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ghareghomi S, Arghavani P, Mahdavi M,
Khatibi A, García-Jiménez C and Moosavi-Movahedi AA:
Hyperglycemia-driven signaling bridges between diabetes and cancer.
Biochem Pharmacol. 229:1164502024. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lomelí Martínez SM, Cortés Trujillo I,
Martínez Nieto M and Mercado González AE: Periodontal disease: A
silent factor in the development and progression of diabetic
retinopathy. World J Diabetes. 15:1672–1676. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bowers LW, Rossi EL, O'Flanagan CH,
deGraffenried LA and Hursting SD: The role of the insulin/IGF
system in cancer: Lessons learned from clinical trials and the
energy balance-cancer link. Front Endocrinol (Lausanne). 6:772015.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kang JS, Choi YJ, Byun Y, Han Y, Kim JH,
Lee JM, Sohn HJ, Kim H, Kwon W and Jang JY: Radiological tumour
invasion of splenic artery or vein in patients with pancreatic body
or tail adenocarcinoma and effect on recurrence and survival. Br J
Surg. 109:105–113. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Dillon DL, Park JY, Mederos MA, Seo YJ,
King J, Hines J, Donahue T and Girgis MD: Neoadjuvant chemotherapy
is associated with improved disease-free survival in pancreatic
cancer patients undergoing pancreaticoduodenectomy with vascular
resection. J Surg Oncol. 130:72–82. 2024. View Article : Google Scholar : PubMed/NCBI
|
